Form 4: CTO Mira Lacous Boosts BIO-key Stake via ESPP

BIO-key International's Chief Technology Officer, Mira Lacous, acquired 2,500 shares of common stock at $0.46 per share through an employee stock purchase plan.

Summary

• Mira K. Lacous, Chief Technology Officer of BIO-KEY International, Inc. (BKYI), acquired 2,500 shares of common stock.
• The transaction occurred on December 31, 2025, at a price of $0.46 per share.
• These shares were acquired under the BIO-key International, Inc. 2021 Employee Stock Purchase Plan (ESPP).
• Following this transaction, Ms. Lacous beneficially owns 38,258 shares of common stock.
• The transaction is exempt under SEC Rules 16b-3(d) and 16b-3(c).
• Holdings do not include options to purchase 87 shares.

Sentiment

Score: 6

Explanation: The acquisition of shares by a Chief Technology Officer, even a relatively small amount through an ESPP, is a mildly positive signal as it indicates continued insider investment and alignment with shareholder interests.

Positives

• An insider, the Chief Technology Officer, increased her direct ownership in the company by acquiring 2,500 shares.
• Acquisition through an Employee Stock Purchase Plan (ESPP) demonstrates management's participation in employee benefit programs and aligns their interests with shareholders.

Future Outlook

NA

Industry Context

This filing reports a routine insider transaction and does not provide broader industry context or trends. It reflects an individual officer's participation in an employee stock purchase plan.

Stakeholder Impact

• Shareholders: The acquisition by a key officer may be viewed as a positive signal of confidence in the company's future, potentially aligning management interests with shareholder value.

Key Dates

Keywords

BKYI, BIO-KEY International, Insider Transaction, Form 4, Stock Purchase, ESPP, Chief Technology Officer, Equity Acquisition